Related Experiment Videos
Combined modality therapy in low risk (T2N0) rectal cancer
C Coco1, P Magistrelli, G Netri
1Istituto di Patologia Chirurgica, Università Cattolica del S. Cuore, Policlinico A. Gemelli, Roma, Italy.
Rays
|April 1, 1995
Summary
Local excision (LE) with adjuvant radiotherapy offers a viable treatment for select rectal cancer patients. This approach achieved high survival rates and low recurrence in early-stage distal rectal tumors.
Area of Science:
- Oncology
- Surgical Oncology
- Radiation Oncology
Background:
- Rectal cancer treatment often involves extensive surgery.
- Minimally invasive options are sought for early-stage disease.
- Local excision (LE) is a potential alternative for selected rectal cancers.
Purpose of the Study:
- To report the experience with local excision (LE) and adjuvant radiotherapy for selected distal rectal cancer cases.
- To evaluate the efficacy and safety of this combined treatment approach.
Main Methods:
- Retrospective analysis of 41 patients with distal rectal cancer undergoing elective LE.
- Strict selection criteria included tumor location, size, mobility, and clinical/histological staging (T1-2 N0M0, G1-2).
- Adjuvant radiotherapy was administered to T2 tumors post-LE.
Main Results:
- 0% operative mortality and 7.3% morbidity.
- 90% of cases achieved radical and curative surgery.
- Low rates of local recurrence (5.4%), overall disease (8.1%), and cancer-specific mortality (5.4%).
- 5-year actuarial survival was 90% for T1 and T2 tumors.
Conclusions:
- Local excision combined with adjuvant radiotherapy is a safe and effective therapeutic option for selected T1 and T2 distal rectal cancers.
- This approach represents a valid alternative to more radical surgical procedures.
- Careful patient selection is crucial for successful outcomes.